Head-to-head trial of 2 diabetes drugs yields mixed results (EurekAlert, 6 November 2012)

07 Nov 2012


An international trial published in The Lancet compares efficacy and safety of daily injections of liraglutide (Victoza) vs weekly injections of exenatide (Bydureon) in patients with type 2 diabetes.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story